Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Boston Scientific, Inc.
FDA approves implant
May 14th, 2003
The U.S. Food and Drug Administration has approved Enteryx, a permanently implanted device to help patients with symptoms of gastroesophageal reflux disease (GERD), a condition in which some of the stomach's contents - including acid - flows up into the esophagus, causing heartburn and/or burning pain in the chest or back of the throat. More than 60 million American adults experience GERD, and about 25 million of them have daily symptoms. Inserted through an endoscope procedure, this device prevents the reflux of stomach acid into the throat, potentially allowing patients with chronic GERD to avoid daily medications. Mild...
Source: Biotech Week (2003-05-14)
|
